tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Nakanishi Inc. Reports Decline in Q3 2025 Financial Performance

Story Highlights
  • Nakanishi Inc. saw a slight increase in net sales but a decline in operating and ordinary income for Q3 2025.
  • The company plans to increase its year-end dividend despite a decrease in its equity ratio.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Nakanishi Inc. Reports Decline in Q3 2025 Financial Performance

Meet Your ETF AI Analyst

An announcement from Nakanishi ( (JP:7716) ) is now available.

Nakanishi Inc. reported a decline in its financial performance for the third quarter of 2025, with net sales increasing slightly by 3.8%, but operating income and ordinary income decreasing by 7.5% and 11.0% respectively. The company’s equity ratio also saw a decrease from 76.3% to 73.3%. Despite these challenges, Nakanishi plans to increase its year-end dividend, indicating a commitment to shareholder returns.

The most recent analyst rating on (JP:7716) stock is a Hold with a Yen2222.00 price target. To see the full list of analyst forecasts on Nakanishi stock, see the JP:7716 Stock Forecast page.

More about Nakanishi

Nakanishi Inc. operates in the manufacturing industry, primarily focusing on producing high-precision dental and medical instruments. The company is listed on the Tokyo Stock Exchange and is known for its innovative solutions in the healthcare sector.

Average Trading Volume: 191,185

Technical Sentiment Signal: Hold

Current Market Cap: Yen177.6B

See more insights into 7716 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1